ABBV vs. TSM: AbbVie vs. Taiwan Semiconductor Mfg Stock Comparison

Company Profile

AbbVie (ABBV) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Taiwan Semiconductor Mfg (TSM) belongs to Information Technology (Semiconductors & Semiconductor Equipment) — their GICS classifications point to very different parts of the market.

AbbVie (ABBV) trades as ordinary local shares, while Taiwan Semiconductor Mfg (TSM) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Taiwan Semiconductor Mfg (TSM) has an aggressive beta of 1.45, indicating higher sensitivity to broad-market moves, while AbbVie (ABBV) is defensive at 0.21 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Capital efficiency shows on one side only: Taiwan Semiconductor Mfg (TSM) earns 41.86% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.

For every dollar of sales, both AbbVie (ABBV) at 15.67% and Taiwan Semiconductor Mfg (TSM) at 51.12% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both AbbVie (ABBV) at 39.59% and Taiwan Semiconductor Mfg (TSM) at 58.66% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Taiwan Semiconductor Mfg (TSM) at 31.61% sits in the top revenue growth quartile, while AbbVie (ABBV) at 8.57% is closer to the peer norm — faster top-line expansion for TSM.

Taiwan Semiconductor Mfg (TSM) at 46.41% sits in the top EPS growth quartile, while AbbVie (ABBV) at -0.84% is closer to the peer norm — faster per-share earnings growth for TSM.

Growth Metrics

Financial Strength

Taiwan Semiconductor Mfg (TSM) at 2.51 keeps current ratio within its industry’s typical mid-range, while AbbVie (ABBV) at 0.87 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for ABBV.

Only one side’s leverage can be read here: Taiwan Semiconductor Mfg (TSM) carries debt-to-equity ratio of 0.12 against its industry range, while AbbVie (ABBV) reports no figure this period.

Financial Strength Metrics

Dividends

Both AbbVie (ABBV) at 2.40% and Taiwan Semiconductor Mfg (TSM) at 1.70% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile Taiwan Semiconductor Mfg (TSM) reports 24.46%, ranking against industry peers normally.

Dividend Metrics

Valuation

Taiwan Semiconductor Mfg (TSM) at 24.33 is near its industry’s usual P/E ratio, while AbbVie (ABBV) at 50.05 sits in the richer quartile — ABBV needs stronger growth or earnings quality to justify the premium.

Taiwan Semiconductor Mfg (TSM) at 0.39 sits in the cheaper P/S ratio quartile while AbbVie (ABBV) at 7.80 prices around its industry’s middle — TSM costs less per dollar of sales, though read it alongside growth and margins.

AbbVie (ABBV) reports a negative P/B ratio of -112.34, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Taiwan Semiconductor Mfg (TSM) reports 71.65, ranking against industry peers normally.

Valuation Metrics